Home Shinobi Therapeutics

Shinobi Therapeutics

In operation
Series A
iPS-T Cell Therapy Researcher
Basic
Enterprise Profile

Basic Information

Shinobi Therapeutics is a biotechnology company headquartered in San Francisco, California, and Kyoto, Japan, dedicated to developing a new class of immune-evasive iPS-T cell therapies.
Shinobi Therapeutics Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2023
contact@shinobitx.com

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Targeted Technology Immunological Techniques Cell Technology
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs